The rising prevalence of chronic diseases such as diabetes coupled with rise in the diabetic population globally are the key factors driving the pen needles market.
The rising prevalence of chronic diseases such as diabetes coupled with rise in the diabetic population globally are the key factors driving the pen needles market.
Increasing worldwide prevalence of diabetes and obesity will spur Pen Needles Market growth during the forecast period. As per International Diabetes Federation, the global prevalence of diabetes was 415 million in 2015 and expected to reach 642 million by 2040. Increasing obese population will accelerate the prevalence of chronic diseases such as diabetes, high blood pressure, coronary heart diseases and stroke.
The global pen needles market size was valued at $1.7 billion in 2022, and is projected to reach $4.5 billion by 2032, growing at a CAGR of 10.3% from 2023 to 2032.
The Global Pen Needles Market study focuses major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. It provides information on trends and developments, and focuses on markets and materials, capacities and technologies, and on the changing structure.
According to the latest research report by IMARC Group, The global pen needles market size reached US$ 3.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.4 Billion by 2028, exhibiting a growth rate (CAGR) of 14.4% during 2023-2028. More Info:- https://www.imarcgroup.com/pen-needles-market
Global Market Insights add New Global Pen Needles Market report provides in-depth information about market overview, top vendors, Key market highlights, product types, market drivers, challenges, trends, industry landscape, size and forecast, five forces analysis, Key leading countries/Region.
The leading market players in the global pen needles market are Owen Mumford Ltd., Becton Dickinson and Company, Novo Nordisk, Allison Medical, Inc., Ypsomed Holding AG, ArtsanaS.p.a, B. Braun Melsungen AG, HTL Strefa S.A., Terumo Corporation, Ultimed Inc., Vogt Medical Vertrieb, Nipro Corporation, Arkray, Ultimed, Hindustan Syringes And Medical Devices, Glucorx, Berpu Medical Technology, Advacare Pharma, Trividia Health, and other prominent players.
According to the latest research report by IMARC Group, The global pen needles market size reached US$ 3.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.4 Billion by 2028, exhibiting a growth rate (CAGR) of 14.4% during 2023-2028. More Info:- https://www.imarcgroup.com/pen-needles-market
Global Self-Injections Market is expected to rise from its initial estimated value of USD 34.94 billion in 2018 to an estimated value of USD 173.75 billion by 2026, registering a CAGR of 22.2% in the forecast period of 2019-2026. This rise in market value can be attributed to rising demand of self-injection devices.
VISIT HERE @ http://www.grandresearchstore.com/packaging/global-pen-needles-market-research-report-2016 This report provided by GrandResearchStore is about,Pen Needles in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Novo Nordisk A/S Becton BD Dickinson
The latest report by Future Market Insights titled ‘Safety Needles Market: Global Industry Analysis and Opportunity Assessment, 2017–2027’ is a comprehensive report that charts the course of the global safety needles market for a period of 10 years from 2017 till 2027. A valuable feature of the report is the regional price forecast of safety needles, which is broken down into different types of needles ranging from Cannula needles to Fine Aspirating needles. In one section of the report, per unit pricing of the different types of safety needles is given for the years 2017 and 2027.
The Insulin Pen Needles research report recognizes and gets fundamental and various sorts of market frameworks under development. Moreover, the Insulin Pen Needles research report successfully consolidates procurement by distinguishing central parts with the most encouraging business sector. Likewise, the information figures massive contender data, examination, and bits of knowledge to develop R&D systems further. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=6690771
According to the latest research report by IMARC Group, The global hypodermic needles market size reached US$ 2.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.1 Billion by 2028, exhibiting a growth rate (CAGR) of 6.9% during 2023-2028. More Info:- https://www.imarcgroup.com/hypodermic-needles-market
The global Needles Market is highly fragmented due to the presence of a various large number of players which forms a competitive environment. The report entails all-inclusive information associated with the latest market updates such as new ideas, market size, opportunity, growth path and trends for the forecast period of 2019-2025 to gain competitive edge across the globe. This report also highlights various important strategic mergers and acquisitions, company overview, financial details, and the latest development undertaken.
Insulin Delivery Devices Market to 2025 - Global Analysis and Forecasts by Product and End User, the global insulin delivery devices market was valued at US$ 11,869.0 Mn in 2017 and is estimated to reach US$ 22,830.0 Mn by 2025. The market is estimated to grow with a CAGR of 8.7% from 2018-2025
Australia Diabetes Market is expected to reach USD 2.44 Billion by the year 2025. By Continuous Glucose Monitoring, Self Monitoring Blood Glucose Device, Insulin Pen & Pump, Forecast & Company Analysis
Sweden Diabetes Market is expected to be USD 5.82 Billion by the end of the year 2025. By Continuous Glucose Monitoring, Self Monitoring Blood Glucose Device, Insulin Pen & Pump Market, Companies Analysis
Netherlands Diabetes Market is expected to be USD 5.82 Billion by the end of the year 2025. By Continuous Glucose Monitoring, Self Monitoring Blood Glucose Device, Insulin Pen & Pump, Forecast & Companies Analysis
A new report avail by decisiondatabases.com for Global Insulin Pen Needle market which provides an in-depth analysis during the forecast period. This report focuses on top manufactures with capacity, production, price, revenue and market share.
According to Renub Research Analysis Insulin Pen Market is expected to surpass US$ 35 Billion by the end of year 2025. Global Forecast by Diabetes Population, Type, & Company. Call Us : +1 678-302-0700 Follow the Link for More Information: https://www.renub.com/insulin-pen-market-p.php
Medtronic, B. Braun Melsungen AG, Becton, Dickinson and Company, Terumo Corporation, Smiths Medical, Boston Scientific Corporation, Novo Nordisk A/S, Argon Medical Devices, Inc., Stryker Corporation, NIPRO Medical Corporation, Cook Medical, and SERAG-WIESSNER GmbH & Co. are some of the major players operating in the global special purpose needles market.
The global advanced dermatology drug delivery devices market size is expected to grow from USD 3,569.8 million in 2021 to USD 8,783.0 million by 2030, at a CAGR of 10.5% from 2022 to 2030. The global advanced dermatology drug delivery devices market is driven by factors such as the global efforts in increasing the adoption of connected devices, increasing number of business synergies with pharmaceutical companies, novel technologies in drug delivery, and the growing focus on prescription/medication adherence. Manufacturers are more focused on producing devices that offer enhanced patient experience through real-time monitoring and data sharing.
According to #TechSci Research report, India Diabetes Care Market was valued at USD1530.3 million in value terms in FY2020 and is forecast to grow at CAGR of 7.94% in value terms to reach USD2408.39 million by FY2026. Gain more Insight: https://bit.ly/37a2lRW Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/
Diabetes Reusable Insulin Pen Market is likely to reach more than US$ 3 Billion across the ten major markets.https://www.bharatbook.com/healthcare-market-research-reports-891014/global-diabetes-reusable-insulin-pen-analysis.html
The rising prevalence of chronic diseases, including obesity and diabetes, is among the key factors driving the US insulin market. In addition to this, the escalating demand for insulin therapeutics is further propelling the market growth. Moreover, the growing requirement for biosimilar drugs, owing to their high efficiency and cost-effectiveness, is acting as another significant growth-inducing factor.
Respiratory Disease Testing Market should witness substantial growth due to increased prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma over the last few years. Increasing pollution and tobacco consumption coupled with rising geriatric population base and technological advancement in respiratory devices should drive respiratory disease testing market size over the forecast period.
Big Market Research throws light on "Global and Chinese Insulin Pen Needle Industry, 2015 Market Research Report" Read Complete Report On: http://www.bigmarketresearch.com/global-and-chinese-insulin-pen-needle-industry-2015-research-report-market The Global and Chinese Insulin Pen Needle Industry, 2010-2020 Market Research Report is a professional and in-depth study on the current state of the global Insulin Pen Needle industry with a focus on the Chinese market. The report provides key statistics on the market status of the Insulin Pen Needle manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
The factors that drive the growth of human insulin industry are rise in awareness regarding diabetes, development and growing investments for drug discovery. Although, strict rules for approval of drug, restricted access to human insulin in developing countries and irregular prices are hindering the growth of human insulin market globally.
The Global Injectable Drug Delivery Market accounted for $26.8 billion in 2014 and is expected tgrow at a CAGR of 13.9% treach $76.1 billion by 2022. The factors driving the injectable drug delivery market include rising incidences of chronic diseases, technological advancements and increase in demand for self injection devices. Chronic disease rates are increasing at 14% each year. In 2012, 63% of the deaths across the world were due tchronic diseases.
AdroitMarketResearch.com just released a new market research report focusing on the “Insulin Market with Global analysis and forecasts until 2025” to its database.
The healthcare practitioners try to minimize the possibilities of needle infections such as hepatitis, cross contamination of HIV and other needle stick injuries (NSI).
North America is the largest regional market, which is estimated to cross US$ 1,200 Mn, or 31.1% share of the total market share in 2017 and is estimated to reach a market valuation in excess of US$ 2,500 Mn by 2027, registering a CAGR of 7.3% over the forecast period. APEJ is the fastest growing market, which is expected to grow from nearly US$ 540 Mn in 2017 to over US$ 1,100 Mn by 2027.
VISIT HERE @ http://www.grandresearchstore.com/medical-devices/human-insulin-market---drugs-biologics-biosimilars-type-short-acting-long-acting-premixed-brands-lantus-novorapid-humalog-delivery-devices-pens-pen-needles-syringes-applications-type-1-diabetes-type-2-diabetes---forecasts-to-2020 The global human insulin market is poised to reach ~USD 39.13 billion by 2020 growing at a CAGR of 8.1% from 2015 to 2020. North America is expected to hold the largest share of the global human insulin market in 2015. Market growth of human insulin products is being propelled by growing diabetes patient population
The report “Human Insulin Market - Drugs (Biologics, Biosimilars), Type (Short Acting, Long Acting, Premixed), Brands (Lantus, NovoRapid, Humalog), Delivery Devices (Pens, Pen Needles, Syringes), Applications (Type 1 Diabetes, Type 2 Diabetes) - Forecasts to 2020” analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
Global Human Insulin Drugs and Delivery Devices Market, By Product (HI Drugs, HI Delivery Devices), Drugs (Insulin Analogs & Biosimilar, HI Biologics), Delivery Device (Syringes, Pens, Pen Needles), Application (Type I Diabetes, Type II Diabetes), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026
Global Human Insulin Drugs and Delivery Devices Market, By Product (HI Drugs, HI Delivery Devices), Drugs (Insulin Analogs & Biosimilar, HI Biologics), Delivery Device (Syringes, Pens, Pen Needles), Application (Type I Diabetes, Type II Diabetes), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026
Global Human Insulin Drugs and Delivery Devices Market, By Product (HI Drugs, HI Delivery Devices), Drugs (Insulin Analogs & Biosimilar, HI Biologics), Delivery Device (Syringes, Pens, Pen Needles), Application (Type I Diabetes, Type II Diabetes), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026
Global Human Insulin Drugs and Delivery Devices Market, By Product (HI Drugs, HI Delivery Devices), Drugs (Insulin Analogs & Biosimilar, HI Biologics), Delivery Device (Syringes, Pens, Pen Needles), Application (Type I Diabetes, Type II Diabetes), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026
Global Human Insulin Drugs and Delivery Devices Market, By Product (HI Drugs, HI Delivery Devices), Drugs (Insulin Analogs & Biosimilar, HI Biologics), Delivery Device (Syringes, Pens, Pen Needles), Application (Type I Diabetes, Type II Diabetes), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026
Global Human Insulin Drugs and Delivery Devices Market, By Product (HI Drugs, HI Delivery Devices), Drugs (Insulin Analogs & Biosimilar, HI Biologics), Delivery Device (Syringes, Pens, Pen Needles), Application (Type I Diabetes, Type II Diabetes), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026
Global Human Insulin Drugs and Delivery Devices Market, By Product (HI Drugs, HI Delivery Devices), Drugs (Insulin Analogs & Biosimilar, HI Biologics), Delivery Device (Syringes, Pens, Pen Needles), Application (Type I Diabetes, Type II Diabetes), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026
The Global and Chinese Insupe Sterile Pen Needle Industry, 2011-2021 Market Research Report is a professional and in-depth study on the current state of the global Insupe Sterile Pen Needle industry with a focus on the Chinese market.
According to the latest research report by IMARC Group, The global human insulin market size reached US$ 48.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 84.2 Billion by 2032, exhibiting a growth rate (CAGR) of 6.2% during 2024-2032. More Info:- https://www.imarcgroup.com/human-insulin-market
The injectable drug delivery devices market consists of sales of injectable drug delivery devices and related products such as conventional syringes, needle-free injectors, auto injectors and pen injectors by entities (organizations, sole traders, and partnerships). The market includes the sales of the injectable devices that have been extensively utilized for various routes of drug administration, such as intravenous, subcutaneous, intradermal, intra-peritoneal, and intra-muscular and others to treat medical conditions ranging from cancer, diabetes to autoimmune disorders.
'Insulin Delivery Devices Market to 2019 Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers' looks at the market, competitive landscape, and trends for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics.
According to the latest research report by IMARC Group, The global human insulin market size reached US$ 45.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 68.0 Billion by 2028, exhibiting a growth rate (CAGR) of 6.48% during 2023-2028. More Info:- https://www.imarcgroup.com/human-insulin-market
This report focuses on Microneedling Cartridges volume and value at global level, regional level and company level. From a global perspective, this report represents overall Microneedling Cartridges market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
Disposable medical supplies represent the largest segment within the global healthcare equipment and supplies sector. For More Details: http://goo.gl/PtXuV9
The global autoinjectors market size is expected to reach USD 170.16 Billion in 2028 at a steady CAGR, according to latest analysis by Emergen Research.
Auto-Injectors Market: Rising Incidence of Anaphylaxis Attack Among the Adult Population Expected to Elevate the Demand for Auto-Injectors: Global Industry Analysis and Opportunity Assessment 2016-2026